Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 16, Iss. 4, 2010-02 ,pp. : 392-410

Bentham Science Publishers

Access to resources Recommend Favorite

The -opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the l-arginine/nitric oxide/cyclic GMP pathway

By Amarante L.H.   Duarte I.D.G.  

European Journal of Pharmacology, Vol. 454, Iss. 1, 2002-11 ,pp. : 19-23

Elsevier

Access to resources Recommend Favorite

The effect of cyclosporin A on morphine tolerance and dependence: involvement of l-arginine/nitric oxide pathway

By Homayoun H.   Khavandgar S.   Namiranian K.   Dehpour A.R.  

European Journal of Pharmacology, Vol. 452, Iss. 1, 2002-09 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Influence of the l-arginine-nitric oxide pathway on vasoactive intestinal polypeptide release and motility in the rat stomach in vitro

By Willis S.   Allescher H.-D.   Weigert N.   Schusdziarra V.   Schumpelick V.  

European Journal of Pharmacology, Vol. 315, Iss. 1, 1996-11 ,pp. : 59-64

Elsevier

Access to resources Recommend Favorite

Regulation of blood pressure by l-arginine-nitric oxide pathway within the superior colliculus of rats

By D'Amico M.   Rossi F.   Warner T.D.  

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 65-67

Elsevier

Access to resources Recommend Favorite